Kodikaz Therapeutic Solutions

Kodikaz Therapeutics

Kodikaz Therapeutics develops a cell-specific non-viral delivery platform for targeted gene therapies to treat various cancers for patients and healthcare providers.

Phost'in Therapeutics

This deep-tech company develops small molecule glycocalyx modifiers to treat patients with aggressive solid tumours by restoring immune responses against cancer cells.

Granza Bio

This deep-tech company develops attack particle medicines to treat patients with cancer, autoimmune diseases and infections.

EditForce

This deep-tech firm develops RNA editing tools and therapies for pharmaceutical, industrial, and agricultural organisations to treat diseases and manipulate genes.

GenEdit

This deep-tech firm develops polymer nanoparticle delivery systems for genetic medicines to treat autoimmune diseases for the pharmaceutical and biotechnology industries.

ParcelBio

This deep-tech firm develops mRNA delivery technologies and programmable medicines for biotechnology and pharmaceutical organisations to treat autoimmune diseases and oncology.

PanTher Therapeutics

This deep-tech company develops polymer-based drug delivery systems for continuous, localised chemotherapy treatment for patients with solid tumours, specifically pancreatic cancer.

Type6 Therapeutics

This deep-tech company develops kinase inhibitors for cancer treatment, intercepting enzymes in their inactive states to address drug resistance for patients with aggressive tumours.